Welcome To BTX Online !   

AgilePulse® Press Release

NEW Advanced Electroporation System for Vaccine Development

The New AgilePulse® In Vivo Electroporation System possesses unique, variable pulse amplitude technology for vaccine delivery or gene therapy applications.

Patented Pulse Agile® waveforms consist of multiple, low to high voltage pulses with variable pulse lengths, which promotes greater cell membrane poration; resulting in maximum transfection efficiency with minimal damage to the cells or tissues. Gene expression in skin is 100-fold higher1 when delivery is enhanced by electroporation compared to injection alone.

Patented Pulse Agile® technology
Resistance measurement for proper needle placement and reproducibility
Specially designed needle arrays for intra-muscular or intra-dermal applications


Enhanced immune response1
Increased Ag-specific T-cell response1
Gene expression is 100-fold higher1


To learn more about this exciting new technology or other BTX electroporation or electrofusion products, please contact us.

1 Roos, A-K, et al., 2009 PLoS One 4(9)